In the dynamic landscape of pharmaceutical research and development, the precise identification and reliable sourcing of chemical intermediates are foundational. One such compound, 5-Bromo-7-azaindole (CAS 183208-35-7), has garnered significant attention for its pivotal role in synthesizing advanced pharmaceutical agents. As a dedicated supplier of these essential materials, understanding its attributes is key to serving the needs of the scientific community.

5-Bromo-7-azaindole, typically presented as a white to yellow crystalline powder, is a fundamental organic chemical intermediate. Its molecular structure (C7H5BrN2) and molecular weight (197.03) are critical parameters for chemists engaged in synthetic organic chemistry. The compound's purity, often exceeding 99.0%, is a testament to the meticulous manufacturing processes employed by reputable suppliers. This high purity is non-negotiable for its application as a precursor in the synthesis of Active Pharmaceutical Ingredients (APIs), where even minor impurities can compromise the efficacy and safety of the final drug product. For researchers seeking to buy 5-bromo-7-azaindole, confirming these specifications with the manufacturer is a standard and essential step.

The pharmaceutical applications of 5-Bromo-7-azaindole are broad and impactful. It is extensively used as an intermediate in the development of novel therapeutic compounds, including those targeting cancer (such as intermediates for ABT199), viral infections, and neurological disorders. Its chemical structure lends itself to various derivatizations, making it a versatile building block for medicinal chemists designing new drug candidates. Moreover, its role in creating fluorescent probes for biological imaging further highlights its importance across different scientific disciplines. The demand for this chemical intermediate underscores the need for reliable global suppliers who can consistently deliver quality material at competitive prices.

As a key player in the chemical supply chain, understanding the market dynamics for intermediates like 5-Bromo-7-azaindole is crucial. Manufacturers in regions like China often provide advantageous pricing and robust production capabilities, making them attractive partners for research institutions and pharmaceutical companies worldwide. When looking to purchase 5-bromo-7-azaindole, engaging with suppliers who offer comprehensive technical data, such as Certificates of Analysis (CoA) and Safety Data Sheets (SDS), is highly recommended. This diligence ensures that procurement aligns with both scientific requirements and regulatory standards, facilitating the advancement of critical research and drug development projects.